CUBIST PHARMACEUTICALS INC's ticker is and the CUSIP is 229678AD9. A total of 52 filers reported holding CUBIST PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $1,843,000 | +37.1% | 532,000 | -7.8% | 0.00% | – |
Q3 2014 | $1,344,000 | -5.0% | 577,000 | 0.0% | 0.00% | – |
Q2 2014 | $1,414,000 | -4.1% | 577,000 | 0.0% | 0.00% | – |
Q1 2014 | $1,474,000 | -13.7% | 577,000 | -17.8% | 0.00% | – |
Q4 2013 | $1,708,000 | +13.9% | 702,000 | +5.2% | 0.00% | – |
Q3 2013 | $1,500,000 | +28.4% | 667,000 | 0.0% | 0.00% | – |
Q2 2013 | $1,168,000 | – | 667,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polar Asset Management Partners Inc. | 42,638,000 | $147,969,000 | 7.88% |
EQUITEC SPECIALISTS, LLC | 7,624,000 | $26,412,000 | 6.82% |
PIPER SANDLER & CO. | 3,852,000 | $13,345,000 | 6.50% |
WOLVERINE ASSET MANAGEMENT LLC | 54,453,000 | $188,885,000 | 3.68% |
WHITEBOX ADVISORS LLC | 13,700,000 | $47,462,000 | 1.90% |
CAMDEN ASSET MANAGEMENT L P /CA | 14,650,000 | $50,753,000 | 1.88% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,630,000 | $74,935,000 | 0.96% |
Jabre Capital Partners S.A. | 2,500,000 | $8,693,000 | 0.89% |
BNP PARIBAS FINANCIAL MARKETS | 11,000,000 | $38,108,179,000 | 0.14% |
BLACKROCK ADVISORS LLC | 22,363,000 | $77,474,000 | 0.08% |